This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoo, B. C. Articles by Park, J.-G. Search for Related Content PubMed PubMed Citation Articles by Yoo, B. C. Articles by Park, J.-G.

Metabotropic Glutamate Receptor 4-Mediated 5-Fluorouracil Resistance in a Human Colon Cancer Cell Line

¹ Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea, and ² Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea

Purpose: 5-Fluorouracil (5-FU) has been the mainstay treatment for colorectal cancer for the past few decades. However, as with other cancers, development of 5-FU resistance has been a major obstacle in colorectal cancer chemotherapy. The purpose of this study was to gain further understanding of the mechanisms underlying 5-FU resistance in colorectal cancer cells.

Experimental Design: A 5-FU-resistant cell line was established from the human colon cancer cell line SNU-769A. Protein extracts from these two cell lines (parent and resistant) were analyzed using comparative proteomics to identify differentially expressed proteins.

Results: 5-FU-resistant human colon cancer cells were found to overexpress metabotropic glutamate receptor 4 (mGluR4). Other experiments showed cellular resistance to 5-FU (i.e., cell survival) was altered by the mGluR4 agonist L-2-amino-4-phosphonobutyric acid (L-AP 4), and by the mGluR4 antagonist (S)-amino-2-methyl-4-phosphonobutanoic acid (MAP 4), in that L-AP 4 increased 5-FU resistance in SNU-769A cells, whereas MAP 4 ablated 5-FU resistance in 5-FU-resistant cells. However, there was no significant effect of L-AP 4 or MAP 4 on basal cAMP and thymidylate synthase levels. Interestingly, 5-FU down-regulated mGluR4 expression, and MAP 4 suppressed proliferation in both cell lines.

Conclusions: We here report mGluR4 expression in human colon cancer cell line, which provides further evidence for extra-central nervous system expression of glutamate receptors. Overexpression of mGluR4 may tentatively be responsible for 5-FU resistance and, although activation by agonist promotes cell survival in the presence of 5-FU, decreased mGluR4 expression or inactivation by antagonist contributes to cell death.

This article has been cited by other articles:

				H. J. Chang, B. C. Yoo, S.-B. Lim, S.-Y. Jeong, W. H. Kim, and J.-G. Park Metabotropic Glutamate Receptor 4 Expression in Colorectal Carcinoma and Its Prognostic Significance Clin. Cancer Res., May 1, 2005; 11(9): 3288 - 3295. [Abstract] [Full Text] [PDF]

				Y.-K. Shin, B. C. Yoo, H. J. Chang, E. Jeon, S.-H. Hong, M.-S. Jung, S.-J. Lim, and J.-G. Park Down-regulation of Mitochondrial F1F0-ATP Synthase in Human Colon Cancer Cells with Induced 5-Fluorouracil Resistance Cancer Res., April 15, 2005; 65(8): 3162 - 3170. [Abstract] [Full Text] [PDF]